Dr. Demian Dana Rose, MD, PhD

Dr. Rose practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Rose's NPI, 1083642342, was assigned on June 28, 2006. Dr. Rose graduated from University of Illinois College of Medicine - Chicago in 2002. Dr. Rose holds California license A84681.

Dr. Rose's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Rose's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Rose to 4 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rose practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Rose's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Rose is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Rose is licensed in California.

Dmand AI lists adjustment disease, anxiety, bipolar disorder, depression, drug use disorders, insomnia, intellectual and developmental disabilities and schizophrenia among the conditions Dr. Rose treats.

CMS data shows 365 Medicare services from Dr. Rose across 2 procedure codes in 2024, for 64 Medicare patients. Medicare paid $27,627 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 64 Medicare patients who saw Dr. Rose in 2024. The largest group is under 65, with 47 patients. 75% of them have schizophrenia and other psychoses, and 58% have anxiety. 73% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rose's median patient age at 37, with 35% women.

In 2024, Dr. Rose wrote 328 Medicare Part D claims for 34 patients. 92% of them were for generic drugs. CMS names the drug for 192 of them, across 8 drugs with 11 or more claims each, at $23,859 in total drug cost. In 2023, CMS named 172 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Rose for performance year 2024, reported as part of a group. Dr. Rose accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rose as offering telehealth.

CMS Open Payments shows 1 general payment to Dr. Rose from 1 drug or device company in 2022. Food and beverage make up the largest share, 100% of the total. Otsuka Pharmaceutical Development & Commercialization, Inc. paid the most, $99.

Dr. Rose graduated from University of Illinois College of Medicine - Chicago in 2002.

Dr. Rose is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.